Efficacy of azithromycin in severe asthma from the AMAZES randomised trial

BACKGROUND: Low-dose azithromycin is an effective therapy for persistent asthma; however, its benefit in severe asthma is not defined. METHODS: Participants with severe asthma were identified from the AMAZES randomised, placebo-controlled trial of long-term (48 weeks) low-dose azithromycin. Particip...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:ERJ Open Res
Autors principals: Gibson, Peter G., Yang, Ian A., Upham, John W., Reynolds, Paul N., Hodge, Sandra, James, Alan L., Jenkins, Christine, Peters, Matthew J., Marks, Guy B., Baraket, Melissa, Powell, Heather, Simpson, Jodie L.
Format: Artigo
Idioma:Inglês
Publicat: European Respiratory Society 2019
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6926362/
https://ncbi.nlm.nih.gov/pubmed/31886156
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/23120541.00056-2019
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars